Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
FDA Status BPC-157s FDA status remains not approved for medical use or over-the-counter sale. In April 2026, compounding restrictions were adjusted, but the peptide still cannot be prescribed or sold for human/animal consumption
CJC-1295 is a peptide that is a synthetic analogue of growth hormone-releasing hormone (GHRH) and is a potent stimulator of both GH and IGF-1
Circulating MOTS-c declines with age and tracks with insulin resistance, making it both a potential longevity biomarker and a therapeutic target
In regulatory speak, this means: significant safety concerns. Compounding pharmacies can no longer legally produce it for human use
NCBI Bookshelf Best practices for injection (asepsis, preparation, and administration) Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides
US$ 24.62
US$ 26.75
US$ 24.14
US$ 23.08
US$ 27.23
US$ 26.53
